gdufa iii: controlled correspondence
Published 1 year ago • 2.8K plays • Length 8:01
Download video MP4
Download video MP3
Similar videos
-
5:04
gdufa iii: facility readiness
-
2:26:13
redesigned pre-submission meetings in gdufa iii: benefits for anda submission and approval
-
11:19
gdufa iii mcrm external training presentation final
-
17:43
controlled correspondence related to pharmaceutical quality
-
8:40
gdufa
-
14:24
gdufa iii goal date illustrations
-
2:57:33
a deep dive: gdufa iii scientific meetings
-
23:35
division of filing review: helpful tips for submission of an anda or controlled correspondence
-
1:35:18
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 1, pt 4
-
56:55
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 1, pt 1
-
1:26:21
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 2, pt 2
-
51:35
update on gdufa science and research
-
19:49
pre-anda meeting or controlled correspondence? (4of28) generic drugs forum – apr. 3-4, 2019
-
5:53
gdufa ii training ir and dr letters, michael folkendt
-
1:30:14
dmf workshop: gdufa iii enhancements and structured data submissions – session 3
-
8:08
andas: pre-submission facility correspondence (pfc) related to prioritized generic drug submissions
-
1:47:22
generic drugs forum (gdf) 2024: regulatory considerations to enhance generic drug access-day 1, pt 3
-
5:37
gdufa ii training - pre anda product development meetings, robert lionberger
-
6:53
gdufa ii training - dmf update, erin skoda
-
35:52
pre-anda interactions with the fda (6of16) generic drugs forum 2020
-
4:50
gdufa ii training - pre anda program pre submission meetings, robert lionberger
-
10:52
gdufa ii training - requests for reconsideration at the division level under gdufa, priya shah
Clip.africa.com - Privacy-policy